The prevention of virally mediated carcinogenesis;Prävention virus-assoziierter karzinomentstehung

Deutsches Arzteblatt

Volumn 103, Issue 26, 2006, Pages

  Greten, Tim F ^a   Wedemeyer, Heiner ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cancer; Hepatitis; Hepatocellular carcinoma; Liver tumour; Prevention

Indexed keywords

ALPHA INTERFERON; NUCLEOSIDE ANALOG; RIBAVIRIN;

CANCER PREVENTION; CARCINOGENESIS; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; REVIEW; VACCINATION; VIRUS CARCINOGENESIS;

EID: 33747323356     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Bosch FX, Ribes J, Diaz M, und Cleries R: Primary liver cancer: Worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16.
2. Greten TF, Papendorf F, Bleck JS et al.: Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer 2005; 92: 1862-8.
3. Kubicka S, Rudolph KL, Hanke M et al.: Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. Liver 2000; 20: 312-8.
4. El-Serag HB: Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology 2004; 127: S27-34.
5. Davila JA, Morgan RO, Shaib Y, McGlynn KA, ElSerag HB: Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study. Gastroenterology 2004; 127: 1372-80.
6. Wedemeyer H, Meyer S, Manns MP: Hepatitis (HepNet) competence network. Internist (Berl) 2004; 45: 415-21.
7. Chang MH, Chen CJ, Lai MS et al.: Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 1855-9.
8. Wiegand J, Jackel E, Cornberg M et al.: Long-term follow-up after successful interferon therapy of acute hepatitis C. Hepatology 2004; 40: 98-107.
9. Fattovich G: Natural history of hepatitis B. J Hepatol 2003; 39(Suppl. 1): S50-8.
10. Fattovich G, Stroffolini T, Zagni I, Donato F: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004; 127: 535-50.
11. Wiese M, Grungreiff K, Guthoff W, Lafrenz M, Oesen U, Porst H: Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany - a 25-year multicenter study. J Hepatol 2005; 43: 590-8.
12. Vogt M, Lang T, Frosner G et al.: Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341: 866-70.
13. Donato F, Tagger A, Gelatti U et al.: Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002; 155: 323-31.
14. Powell EE, Jonsson JR, Clouston AD, Steatosis: cofactor in other liver diseases. Hepatology 2005; 42: 5-13.
15. Liaw YF, Sung JJ, Chow WC et al.: Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004; 351: 1521-31.
16. Di Marco V, Marzano A, Lampertico P et al.: Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine. Hepatology 2004; 40: 883-91.
17. Camma C, Giunta M, Andreone P, Craxi A: Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 2001; 34: 593-602.
18. Wedemeyer H, Jackel E, Wiegand J, Cornberg M, Manns MP: Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C. Hepatology 2004; 39: 1201-3.
19. Ikeda K, Saitoh S, Arase Y et al.: Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 1999; 29: 1124-30.
20. Muto Y, Moriwaki H, Ninomiya M et al.: Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group. N Engl J Med 1996; 334: 1561-7.